We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
-13.18%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$417M
AUM Growth
-$46.8M
Cap. Flow
+$82.1M
Cap. Flow %
19.68%
Top 10 Hldgs %
71.44%
Holding
87
New
11
Increased
13
Reduced
41
Closed
12

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.56M
2
GILD icon
Gilead Sciences
GILD
+$9.19M
3
USG
Usg
USG
+$4.21M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.7M
5
IBM icon
IBM
IBM
+$2.19M

Sector Composition

Rank Sector Weight
1 Financials 38.81%
2 Energy 20.1%
3 Technology 14.87%
4 Healthcare 11.77%
5 Consumer Staples 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMBA icon
76
Ambarella
AMBA
$3.05B
-5,650
Closed -$219K
BB icon
77
BlackBerry
BB
$4.52B
-32,550
Closed -$370K
BKR icon
78
Baker Hughes
BKR
$61.5B
-7,650
Closed -$259K
GSK icon
79
GSK
GSK
$103B
-4,100
Closed -$206K
KMI icon
80
Kinder Morgan
KMI
$71.6B
-11,010
Closed -$195K
MDLZ icon
81
Mondelez International
MDLZ
$80.5B
-5,980
Closed -$257K
MMM icon
82
3M
MMM
$92.4B
-1,140
Closed -$201K
MSFT icon
83
Microsoft
MSFT
$3.67T
-2,662
Closed -$304K
NOV icon
84
NOV
NOV
$7.15B
-10,610
Closed -$457K
SYNA icon
85
Synaptics
SYNA
$3.76B
-8,170
Closed -$373K
STOR
86
DELISTED
STORE Capital Corporation
STOR
-8,400
Closed -$233K
VIVO
87
DELISTED
Meridian Bioscience Inc
VIVO
-47,585
Closed -$709K

Similar funds

Greylin Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Greylin Investment Management held 87 positions worth $417M, down 10% from $464M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Greylin Investment Management deployed $82.1M of net new capital in Q4 2018, opening 11 new positions and adding to 13 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 200 shares worth $612K.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Merck, an estimated $9.56M trimmed.

  • Greylin Investment Management's largest Q4 2018 buy was Berkshire Hathaway Class A: 200 shares worth $612K.
  • Greylin Investment Management added most to SLB Ltd in Q4 2018, an estimated $15M increase.
  • Greylin Investment Management's biggest Q4 2018 reduction was Merck, cutting an estimated $9.56M.
  • Greylin Investment Management fully exited Meridian Bioscience Inc in Q4 2018, selling an estimated $709K.
  • Greylin Investment Management's ten largest holdings make up 71% of its $417M portfolio in Q4 2018.
  • Greylin Investment Management opened 11 new positions and closed 12 in Q4 2018.
  • Greylin Investment Management's portfolio value fell 10% quarter-over-quarter to $417M.

Based on Greylin Investment Management's 13F filing for Q4 2018, filed 14 Jan 2019.